RNU6-958P

Across TCGA pan-cancer cohorts, RNU6-958P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-958P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-958P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-958P expression acts as an unfavorable survival marker.

BRCA, MESO, and KIRC are the cancer types where RNU6-958P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.721	0.894	<.001	54	view →
MESO	OS	Tertile	II,III,IV	0.121	0.571	.004	54	view →
KIRC	OS	Tertile	II,III,IV	0.152	0.560	.005	51	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.294	0.737	.001	36	view →
STAD	OS	Tertile	III,IV	0.474	0.669	.020	26	view →
LIHC	OS	Tertile	II,III,IV	0.226	0.769	.008	18	view →
SARC	DFS	Tertile	All	0.182	0.594	.031	9	view →
ESCA	DFS	Quartile	All	0.312	0.784	.030	4	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-958P–BRCA (DFS)

Open the BRCA breakdown →